
    
      This study will be a randomized pilot trial of the refined OA-PCP among n=240 patients age
      â‰¥65 with hip and/or knee OA recruited from primary care clinics. Participants will be
      assigned equally to either the OA-PCP or an attention control group. Participants will
      complete assessments at baseline, and 6-month and 12-month follow-up. Primary endpoint of the
      trial will be objectively assessed PA, measured via accelerometer and secondary endpoint will
      be self-reported pain and function.
    
  